Amer Alghabban
Plus aucun poste en cours
Profil
Amer Alghabban worked as a Director at Merck KGaA, a Managing Director at Gxp Compliance & Training Partners, a Senior Audit Manager at Novartis AG, a Global Head-GxP Quality Assurance at Arpida AG, a VP-GxP, Quality Assurance, Compliance & Training at Karyopharm Therapeutics, Inc., and a Compliance Officer at Medicines & Healthcare Products Regulatory Agency.
Anciens postes connus de Amer Alghabban
| Sociétés | Poste | Fin |
|---|---|---|
| Medicines & Healthcare Products Regulatory Agency | Compliance Officer | - |
| NOVARTIS AG | Comptroller/Controller/Auditor | - |
Arpida AG
 Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Corporate Officer/Principal | - |
| MERCK KGAA | Directeur/Membre du Conseil | - |
| Gxp Compliance &Training Partners | Directeur Général | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| MERCK KGAA | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Gxp Compliance &Training Partners | |
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
| Medicines & Healthcare Products Regulatory Agency | Government |
